Unlike basic LLMs, the Microsoft system mimics the sequential logic of diagnosis (reasoning), analyzing symptoms step-by-step. For healthcare macroeconomics (MedTech), this signals an impending radical restructuring. Although the results were obtained under controlled laboratory conditions, they prove that the monopoly of human specialists on primary patient data analytics is broken. The corporate B2B sector is acquiring a tool capable of drastically reducing the cost of diagnostics, though implementation will face unprecedented resistance from medical regulators and insurance companies.
Source: Microsoft AI / Reuters / Science
MedTechMicrosoftB2BR&DMacroeconomics